Close Menu

NEW YORK (GenomeWeb) – Indivumed has partnered with Singapore's Agency for Science, Technology, and Research (A*STAR) to perform proteomics research, with the aim of building out the company's IndivuType global cancer database.

According to Indivumed, IndivuType is an online resource that combines genomic, transcriptomic, proteomic, precision proteomic, and digital histopathology data with clinical information from thousands of cancer patients. It also features bioinformatic and artificial intelligence tools for data analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.